226 related articles for article (PubMed ID: 17785206)
21. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic resistance exhibited by dexamethasone-resistant murine 7TD1 cells is controlled independently of interleukin-6 triggered signaling.
Gangavarapu KJ; Olbertz JL; Bhushan A; Lai JC; Daniels CK
Apoptosis; 2008 Nov; 13(11):1394-400. PubMed ID: 18819004
[TBL] [Abstract][Full Text] [Related]
23. Human cytomegalovirus protects multiple myeloma cell line KM3 cells from apoptosis induced by growth factor withdrawal.
Wei GQ; Lin MF; Huang H; Cai Z
Chin Med J (Engl); 2004 Jun; 117(6):903-7. PubMed ID: 15198896
[TBL] [Abstract][Full Text] [Related]
24. Genistein down-regulates the constitutive activation of nuclear factor-kappaB in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis.
He H; Chen L; Zhai M; Chen JZ
Phytother Res; 2009 Jun; 23(6):868-73. PubMed ID: 19107739
[TBL] [Abstract][Full Text] [Related]
25. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
Carey GB; Semenova E; Qi X; Keegan AD
Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
[TBL] [Abstract][Full Text] [Related]
26. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
Bauer K; Kretzschmar AK; Cvijic H; Blumert C; Löffler D; Brocke-Heidrich K; Schiene-Fischer C; Fischer G; Sinz A; Clevenger CV; Horn F
Oncogene; 2009 Aug; 28(31):2784-95. PubMed ID: 19503092
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
[TBL] [Abstract][Full Text] [Related]
28. Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells.
Lee KW; Kim SG; Kim HP; Kwon E; You J; Choi HJ; Park JH; Kang BC; Im SA; Kim TY; Kim WH; Bang YJ
Cancer Res; 2008 Mar; 68(6):1916-26. PubMed ID: 18339873
[TBL] [Abstract][Full Text] [Related]
29. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
[TBL] [Abstract][Full Text] [Related]
30. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
[TBL] [Abstract][Full Text] [Related]
31. Antimyeloma effects of a sesquiterpene lactone parthenolide.
Suvannasankha A; Crean CD; Shanmugam R; Farag SS; Abonour R; Boswell HS; Nakshatri H
Clin Cancer Res; 2008 Mar; 14(6):1814-22. PubMed ID: 18347184
[TBL] [Abstract][Full Text] [Related]
32. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
33. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
Gadó K; Domján G; Hegyesi H; Falus A
Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
[TBL] [Abstract][Full Text] [Related]
34. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of the calcitonin receptor by myeloma cells in their osteoclast-like activity in vitro.
Silvestris F; Cafforio P; De Matteo M; Quatraro C; Dammacco F
Leuk Res; 2008 Apr; 32(4):611-23. PubMed ID: 17714780
[TBL] [Abstract][Full Text] [Related]
36. Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors.
David E; Sinha R; Chen J; Sun SY; Kaufman JL; Lonial S
Clin Cancer Res; 2008 Aug; 14(16):5090-8. PubMed ID: 18698026
[TBL] [Abstract][Full Text] [Related]
37. Growth inhibition of human multiple myeloma cells by an oncolytic adenovirus carrying the CD40 ligand transgene.
Fernandes MS; Gomes EM; Butcher LD; Hernandez-Alcoceba R; Chang D; Kansopon J; Newman J; Stone MJ; Tong AW
Clin Cancer Res; 2009 Aug; 15(15):4847-56. PubMed ID: 19622582
[TBL] [Abstract][Full Text] [Related]
38. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways.
Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R
Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162
[TBL] [Abstract][Full Text] [Related]
39. Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis.
Balsas P; López-Royuela N; Galán-Malo P; Anel A; Marzo I; Naval J
Biochem Pharmacol; 2009 Mar; 77(5):804-12. PubMed ID: 19100720
[TBL] [Abstract][Full Text] [Related]
40. Notch increased vitronection adhesion protects myeloma cells from drug induced apoptosis.
Ding Y; Shen Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):717-22. PubMed ID: 26494298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
